(Total Views: 630)
Posted On: 10/29/2020 9:26:30 PM
Post# of 154115
In terms of breast cancer, CYDY is enrolling at two sites for the phase 1b/2 trial:
Quest Clinical Research Recruiting
San Francisco, California, United States, 94115
Principal Investigator: Jay Lalezari
United States, Illinois
CD07 Investigational Site Recruiting
Chicago, Illinois, United States, 60611
Quest Clinical Research Recruiting
San Francisco, California, United States, 94115
Principal Investigator: Jay Lalezari
United States, Illinois
CD07 Investigational Site Recruiting
Chicago, Illinois, United States, 60611
(0)
(0)
